| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |